Research published in the journal Leukemia discusses the potential usefulness of a novel genetic test that could identify those at highest risk of disease progression among patients with multiple myeloma and who are unlikely to respond to standard treatment.
Genetic test could flag very high-risk multiple myeloma
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.